Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yueyuan Yin

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Life Science Alliance|October 22, 2021
Single-domain antibody screening by <i>is</i>PLA-seqYueyuan Yin, Fei Yan, Ruimin Zhou, et al.
Cell Death & Disease|December 22, 2025
Targeting intrinsically disordered nuclear protein 1 (NUPR1) with single-domain antibodies alleviates triple-negative breast cancer (TNBC) progression in vivoTianzhuo Wang, Min Wang, Xuanru Chen, et al.
Oncology Reports|January 11, 2020
Combination of AAV‑mediated NUPR1 knockdown and trifluoperazine induces premature senescence in human lung adenocarcinoma A549 cells in nude miceYanzhe Li, Yueyuan Yin, Jinyi Ma, et al.
Cell Death & Disease|February 5, 2021
Transcriptional coregualtor NUPR1 maintains tamoxifen resistance in breast cancer cellsLingling Wang, Jiashen Sun, Yueyuan Yin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Life Science Alliance|October 22, 2021
Single-domain antibody screening by <i>is</i>PLA-seqYueyuan Yin, Fei Yan, Ruimin Zhou, et al.
Cell Death & Disease|December 22, 2025
Targeting intrinsically disordered nuclear protein 1 (NUPR1) with single-domain antibodies alleviates triple-negative breast cancer (TNBC) progression in vivoTianzhuo Wang, Min Wang, Xuanru Chen, et al.
Oncology Reports|January 11, 2020
Combination of AAV‑mediated NUPR1 knockdown and trifluoperazine induces premature senescence in human lung adenocarcinoma A549 cells in nude miceYanzhe Li, Yueyuan Yin, Jinyi Ma, et al.
Cell Death & Disease|February 5, 2021
Transcriptional coregualtor NUPR1 maintains tamoxifen resistance in breast cancer cellsLingling Wang, Jiashen Sun, Yueyuan Yin, et al.
Pageof 1